Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma

Life Sciences

Volumn 68, Issue 10, 2001, Pages 1161-1168

  Ribatti, D ^a   Surico, G ^a   Vacca, A ^a   De Leonardis, F ^a   Lastilla, G ^a   Montaldo, P G ^b   Rigillo, N ^a   Ponzoni, M ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Angiogenesis; Matrix metalloproteinases; Neuroblastoma

Indexed keywords

BLOOD CLOTTING FACTOR 8; GELATINASE A; GELATINASE B; MESSENGER RNA;

ADVANCED CANCER; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER STAGING; CHILD; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; METASTASIS; NEUROBLASTOMA; TUMOR GROWTH;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; RNA, MESSENGER;

EID: 0035951364     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)01030-4     Document Type: Article

References (28)

1. What is the evidence that tumors are angiogenesis dependent?
2. Prolonged tumor dormancy by prevention of neovascularization in the vitreous
3. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
4. Biology and biochemistry of proteinases in tumor invasion
5. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
6. Localized neuroblastoma
7. Neuroblastoma
8. Tumor progression of human neuroblastoma cells tagged with a lacZ marker gene: Earliest events at ectopic injection sites
9. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma
10. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo
11. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
12. Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia
13. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: Association with tumor progression and clinical outcome
14. Matrix metalloproteinase-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis
15. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment
16. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9
17. Complete structure of the human gene for 92-kilodalton type IV collagenase. Divergent regulation of expression for the 92- and 72-kDA enzyme genes in HT-1080 cells
18. Pattern and emerging mechanisms of the angiogenic switch during tumorigenesis
19. The role of matrix metalloproteases anf their inhibitors in tumor invasion, metastasis and angiogenesis
20. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma
21. Spontaneous regression of neuroblastoma
22. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
23. Tumor stroma as a regulator of neoplastic behaviour
24. Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions
25. Bone marrow neovascularization. Plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of multiple myeloma
26. The basic science underlying antiangiogenic therapies
27. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats
28. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma